CompletedNot Applicable

Robotic Natural Orifice Specimen Extraction Surgery Versus Robotic Transabdominal Specimen Extraction Surgery for Early-Stage Rectal Cancer

China636 participantsStarted 2023-10-01

Plain-language summary

A retrospective cohort study, conducted nationwide（China） and across multiple centers, aimed to compare the surgical quality and short-term outcomes of R-NOSES （robotic natural orifice specimen extraction surgery）with R-TSES （robotic transabdominal specimen extraction surgery） for early-stage rectal cancer.

Who can participate

Age range20 Years – 86 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. histologically confirmed rectal adenocarcinoma
✓. robotic TME for rectal adenocarcinoma
✓. postoperative pathological staging of T1-2N0M0
✓. complete surgical and postoperative follow-up information

Exclusion criteria

✕. body mass index (BMI) ≥ 35 kg/m2
✕. history of abdominal surgery
✕. history of pelvic surgery
✕. presence of another primary cancer
✕. previous endoscopic submucosal dissection (ESD) or endoscopic mucosal resection (EMR)
✕. anal or vaginal disease
✕. ileostomy or transverse colostomy
✕. conversion to open operation

What they're measuring

Complication rate

Timeframe: Up to 30 days postoperatively

Trial details

NCT IDNCT06405308

SponsorTaiyuan Li

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-01-15

View on ClinicalTrials.gov More Rectal Cancer trials